Candida glabrata endophthalmitis treated successfully with caspofungin.

Juan C. Sarria, Jay C. Bradley, Ranya Habash, Kelly T. Mitchell, Robert C. Kimbrough, Ana M. Vidal

Research output: Contribution to journalArticlepeer-review

59 Scopus citations


A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.

Original languageEnglish (US)
Pages (from-to)e46-48
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue number5
StatePublished - Mar 1 2005

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Candida glabrata endophthalmitis treated successfully with caspofungin.'. Together they form a unique fingerprint.

Cite this